Cyclic-RGD Peptides Increase the Adenoviral Transduction of Human Mesenchymal Stem Cells
dc.contributor.author | King, William J. | |
dc.contributor.author | Krebsbach, Paul H. | |
dc.date.accessioned | 2017-12-19T21:15:35Z | |
dc.date.available | 2017-12-19T21:15:35Z | |
dc.date.issued | 2012-09-07 | |
dc.identifier.citation | King, William J.; Krebsbach, Paul H. (2012). "Cyclic-RGD Peptides Increase the Adenoviral Transduction of Human Mesenchymal Stem Cells." Stem Cells and Development 22 (4): 679-686. | |
dc.identifier.issn | 1547-3287 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/140200 | |
dc.description.abstract | Human mesenchymal stem cells (hMSCs) have been extensively explored for drug delivery applications due to their safety, immunomodulatory properties, and ability to differentiate into new tissues. The experiments presented in this study were designed to determine peptide-based mechanisms to increase the adenoviral transduction of hMSCs for the purpose of improving their capacity as drug delivery vehicles. Specifically, we demonstrated that cyclic- RGD peptides increased the internalization of adenoviruses into MSCs. MSCs treated with cyclic-RGD peptides had a transduction efficiency of 76.6%±4%, which was significantly greater than the 23.5%±12.2% transduction efficiency of untreated stem cells (P<0.05). Blocking endocytosis with inhibitors of dynamin or actin polymerization decreased the cyclic-RGD-mediated increase in transduction efficiency. MSCs treated with cyclic-RGD and adenoviruses carrying the gene for bone morphogenetic protein-2 produced significantly greater concentrations of this growth factor compared to stem cells treated with only adenoviruses or adenoviruses cocultured with cyclic-RAD peptides. Furthermore, this stem cell-produced bone morphogenetic protein induced alkaline phosphatase expression in C2C12 cells indicating growth factor bioactivity. Taken together, these studies suggest that cyclic-RGD peptides could be used to increase the adenoviral transduction of hMSCs and increase their therapeutic potential. | |
dc.publisher | Mary Ann Liebert, Inc., publishers | |
dc.title | Cyclic-RGD Peptides Increase the Adenoviral Transduction of Human Mesenchymal Stem Cells | |
dc.type | Article | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/140200/1/scd.2012.0379.pdf | |
dc.identifier.doi | 10.1089/scd.2012.0379 | |
dc.identifier.source | Stem Cells and Development | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.